TQB3473, a novel spleen tyrosine kinase inhibitor for primary immune thrombocytopenia: a single-arm, open-label, multicenter phase 1 study. // Journal of Thrombosis and Haemostasis. – URL: https://www.sciencedirect.com/science/article/pii/S1538783626002576?dgcid=rss_sd_all
TQB3473, a novel spleen tyrosine kinase inhibitor for primary immune thrombocytopenia: a single-arm, open-label, multicenter phase 1 study. Journal of Thrombosis and Haemostasis. https://www.sciencedirect.com/science/article/pii/S1538783626002576?dgcid=rss_sd_all
“TQB3473, a novel spleen tyrosine kinase inhibitor for primary immune thrombocytopenia: a single-arm, open-label, multicenter phase 1 study.” Journal of Thrombosis and Haemostasis.
@article{article119118,
title = {TQB3473, a novel spleen tyrosine kinase inhibitor for primary immune thrombocytopenia: a single-arm, open-label, multicenter phase 1 study},
journal = {Journal of Thrombosis and Haemostasis},
url = {https://www.sciencedirect.com/science/article/pii/S1538783626002576?dgcid=rss_sd_all}
}